Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Surgery Partners stock | 24.31

Own Surgery Partners stock in just a few minutes.


Fact checked

Surgery Partners, Inc is a medical care facilities business based in the US. Surgery Partners shares (SGRY) are listed on the NASDAQ and all prices are listed in US Dollars. Surgery Partners employs 6,900 staff and has a trailing 12-month revenue of around USD$1.8 billion.

How to buy shares in Surgery Partners

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Surgery Partners. Find the stock by name or ticker symbol: SGRY. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Surgery Partners reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$24.31, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Surgery Partners, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Surgery Partners. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Surgery Partners share price

Use our graph to track the performance of SGRY stocks over time.

Surgery Partners shares at a glance

Information last updated 2020-11-26.
Latest market close USD$24.31
52-week range USD$4 - USD$26.72
50-day moving average USD$23.3692
200-day moving average USD$18.0321
Wall St. target price USD$26.67
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-5.044

Buy Surgery Partners shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Stocks, Mutual funds, ETFs, Forex
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
or $25 broker-assisted
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Surgery Partners stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Surgery Partners price performance over time

Historical closes compared with the close of $24.31 from 2020-11-16

1 week (2020-11-20) N/A
1 month (2020-10-28) N/A
3 months (2020-08-28) N/A
6 months (2020-05-28) N/A
1 year (2019-11-27) N/A
2 years (2018-11-27) N/A
3 years (2017-11-27) N/A
5 years (2015-11-27) N/A

Is Surgery Partners under- or over-valued?

Valuing Surgery Partners stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Surgery Partners's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Surgery Partners's PEG ratio

Surgery Partners's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.66. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Surgery Partners's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Surgery Partners's EBITDA

Surgery Partners's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$279.3 million.

The EBITDA is a measure of a Surgery Partners's overall financial performance and is widely used to measure a its profitability.

Surgery Partners financials

Revenue TTM USD$1.8 billion
Operating margin TTM 10.38%
Gross profit TTM USD$423.8 million
Return on assets TTM 2.32%
Return on equity TTM -1.48%
Profit margin -7.7%
Book value $2.035
Market capitalisation USD$1.3 billion

TTM: trailing 12 months

Shorting Surgery Partners shares

There are currently 1.8 million Surgery Partners shares held short by investors – that's known as Surgery Partners's "short interest". This figure is 15.7% down from 2.1 million last month.

There are a few different ways that this level of interest in shorting Surgery Partners shares can be evaluated.

Surgery Partners's "short interest ratio" (SIR)

Surgery Partners's "short interest ratio" (SIR) is the quantity of Surgery Partners shares currently shorted divided by the average quantity of Surgery Partners shares traded daily (recently around 418998.61111111). Surgery Partners's SIR currently stands at 4.32. In other words for every 100,000 Surgery Partners shares traded daily on the market, roughly 4320 shares are currently held short.

However Surgery Partners's short interest can also be evaluated against the total number of Surgery Partners shares, or, against the total number of tradable Surgery Partners shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Surgery Partners's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Surgery Partners shares in existence, roughly 30 shares are currently held short) or 0.0767% of the tradable shares (for every 100,000 tradable Surgery Partners shares, roughly 77 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Surgery Partners.

Find out more about how you can short Surgery Partners stock.

Surgery Partners share dividends

We're not expecting Surgery Partners to pay a dividend over the next 12 months.

Surgery Partners share price volatility

Over the last 12 months, Surgery Partners's shares have ranged in value from as little as $4 up to $26.72. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Surgery Partners's is 3.3467. This would suggest that Surgery Partners's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Surgery Partners overview

Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and related services in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of a diagnostic laboratory, multi-specialty physician practices, urgent care facilities, anesthesia services, and optical services. It also operates optical laboratory that manufactures eyewear. As of March 31, 2020, the company owned or operated a portfolio of 127 surgical facilities, including 111 ambulatory surgical centers and 16 surgical hospitals in 30 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site